Emerging drugs for functional dyspepsia (Q37854060)

24 August 2017

1 reference

title

Emerging drugs for functional dyspepsia (English)

1 reference

24 August 2017

Jan Tack

1

1 reference

PubMed ID

21413902

24 August 2017

Pieter Janssen

series ordinal

2

1 reference

PubMed ID

21413902

24 August 2017

language of work or name

English

0 references

publication date

17 March 2011

1 reference

Expert Opinion on Emerging Drugs

24 August 2017

1 reference

24 August 2017

16

1 reference

24 August 2017

283-292

1 reference

24 August 2017

2

1 reference

Functional gastroduodenal disorders

24 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Functional dyspepsia impacts absenteeism and direct and indirect costs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Pathophysiology and treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Gastroduodenal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Japanese herbal medicine in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Prokinetics and fundic relaxants in upper functional GI disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Long-term tegaserod treatment for dysmotility-like functional dyspepsia: results of two identical 1-year cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Prucalopride: a new drug for the treatment of chronic constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Translating 5-HT receptor pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Dose finding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Influence of ghrelin on interdigestive gastrointestinal motility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Promotility medications--now and in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

A placebo-controlled trial of itopride in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

The effects of itopride on oesophageal motility and lower oesophageal sphincter function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Influence of buspirone on gastric sensorimotor function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

The influence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Characterization of functional effects of Z-338, a novel gastroprokinetic agent, on the muscarinic M1, M2, and M3 receptors expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Acotiamide (Z-338) as a possible candidate for the treatment of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Visceral hypersensitivity: facts, speculations, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Clinical trial: a randomized controlled cross-over study of flupenthixol + melitracen in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.2011.558502

Pharmacological interventions for non-ulcer dyspepsia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001960.PUB3

Eradication of Helicobacter pylori for non-ulcer dyspepsia

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002096.PUB4

10.1517/14728214.2011.558502

12 January 2024

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21413902